| Date Filed | Type | Description |
| 03/17/2023 |
4
| Branning Todd P. (CFO) has filed a Form 4 on NeuBase Therapeutics, Inc.|
Txns:
| Granted 54,200 shares
@ $0 |
|
| 11/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/10/2022 |
4
| Branning Todd P. (CFO) has filed a Form 4 on NeuBase Therapeutics, Inc.|
Txns:
| Granted 300,000 options to buy
@ $2.52, valued at
$756k
|
|
| 01/10/2022 |
3
| Branning Todd P. (CFO) has filed a Form 3 on NeuBase Therapeutics, Inc. |
| 01/29/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/13/2020 |
4
| Branning Todd P. (CFO) has filed a Form 4 on Phathom Pharmaceuticals, Inc.|
Txns:
| Granted 85,000 options to buy
@ $29.43, valued at
$2.5M
|
|
| 07/13/2020 |
3
| Branning Todd P. (CFO) has filed a Form 3 on Phathom Pharmaceuticals, Inc. |
| 03/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/23/2020 |
4
| Branning Todd P. (SVP and CFO) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 7,311 shares
@ $5.13, valued at
$37.5k
Exercised 20,096 restricted stock units
@ $0 |
|
| 11/14/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/24/2019 |
4
| Branning Todd P. (SVP, CFO) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Granted 163,666 options
@ $12.44, valued at
$2M
Granted 80,386 restricted stock units
@ $0 |
|
| 01/23/2019 |
3
| Branning Todd P. (SVP, CFO) has filed a Form 3 on Amneal Pharmaceuticals, Inc. |